John Renger - Chief Scientific Officer at Cerevel Therapeutics Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
CERE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

John Renger - trading volume in the past year for Cerevel Therapeutics Holdings, Inc.

Holdings reported by John Renger for Cerevel Therapeutics Holdings, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 15,061 $626 K $41.54 Feb 6, 2024 Direct Common Stock
Common Stock 6,370 $265 K $41.54 Feb 7, 2024 Direct
Stock Option (Right to Buy) 79,022 Feb 6, 2023 Direct Common Stock

Transactions reported by John Renger for Cerevel Therapeutics Holdings, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership